. 2022 Jun 21;15(7):800–805. doi: 10.1016/j.jiph.2022.06.010

Table 3.

Association analysis between demographic and clinical characteristics and clinical outcome of the 579 COVID-19 positive patients.

Characteristics	Medical Discharge (n = 385)	Death (n = 194)	p	OR_crude(IC 95 %)	OR_ajusted(IC 95 %)^a
Sex	n ( %)	n ( %)
Female	162 (42.1)	83 (42.8)	0.9	1^b	1^b
Male	223 (57.9)	111 (57.2)	0.9	0.97 (0.69–1.38)	1.25 (0.78 – 1.99)
Age (years)
20–51	137 (35.6)	20 (10.3)	< 0.001	1^b	1^b
52–64	113 (29.3)	43 (22.2)		2.61 (1.45–4.68)	3.22 (1.54 – 6.72)
65–73	72 (18.7)	65 (33.5)		6.18 (3.47–11.01)	6.52 (3.18 – 13.37)
≥ 74	63 (16.4)	66 (34.0)		7.18 (4.01–12.85)	9.14 (4.39 – 19.02)
Hypertension
No	141 (38.0)	42 (22.6)	< 0.001	1^b	1^b
Yes	230 (62.0)	144 (77.4)	< 0.001	2.10 (1.41 – 3.14)	1.21 (0.69 – 2.11)
No information	14	8
Diabetes Mellitus
No	217 (58.5)	95 (51.1)	0.1	1^b	1^b
Yes	154 (41.5)	91 (48.9)	0.1	1.35 (0.95 – 1.92)	1.33 (0.83 – 2.11)
No information	14	8
Obesity
No	220 (65.3)	120 (66.3)		1^b	1^b
Yes	117 (34.7)	61 (33.7)	0.8	0.96 (0.65 – 1.40)	1.07 (0.64 – 1.79)
No information	48	13
Time to RT-qPCR collection (days)
0–3	37 (13.9)	25 (21.0)	0.17	1^b	1^b
4–10	148 (55.4)	64 (53.8)		0.64 (0.36 – 1.15)	0.75 (0.35 – 1.59)
≥ 11	82 (30.7)	30 (25.2)		0.54 (0.28 – 1.05)	0.53 (0.23 – 1.21)
No information	118	75
Length of hospital stay (days)
0 – 5	130 (33.8)	51 (26.3)	< 0.001	1^b	1^b
6 – 8	101 (26.2)	30 (15.5)		0.76 (0.45–1.27)	0.72 (0.36 – 1.43)
9 – 13	87 (22.6)	42 (21.6)		1.23 (0.75–2.01)	0.92 (0.48 – 1.77)
≥ 14	67 (17.4)	71 (36.6)		2.70 (1.70–4.30)	2.73 (1.49 – 5.02)
Pulmonary impairment
< 50	196 (58.9)	41 (31.8)	< 0.001	1^b	1^b
≥ 50	137 (41.1)	88 (68.2)	< 0.001	3.07 (1.99 – 4.72)	3.38 (2.11 – 5.43)

Adjusted for age, length of hospitalization, and pulmonary impairment, when applicable.

Reference group.